Home Options ADBEReports

ADBE

Adobe Inc.Close $253.37EOD only

Max Pain

$250.00

Next expiry May 22, 2026

Expected Move

±$7.72

3.0% from close

Price Gap

-3.37

Distance to max pain

IV Rank

Middle-high premium

P/C OI

0.74

Slightly call-heavy

Consensus

4/4

Partial coverage

Published snapshot: May 20, 2026 close

End-of-day snapshot

This page reflects ADBE options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot

May 20, 2026 close

ADBE Directional Report

Analysis based on market close March 31, 2026

Directional Theta Gang Flow Earnings Consensus

Historical consensus-supported lens with full content, report chain context, and metric rail.

You are viewing an older report from March 31, 2026. A newer directional report is available for April 2, 2026.

View latest report

Outlook

Neutral-to-bearish with a strong gravitational pull toward the $245 max pain pin for the 3/27 expiry, but a multi-week trend of rising max pain suggests underlying bullish drift. Confidence: 8/10. The regime is defined by negative GEX (trending), high IV, and mixed flow with net put premium, favoring directional strategies with a bearish lean near-term.

Confidence:

8 / 10

base 8; GEX negative supports trending moves, high IV (49.2%) provides edge for premium sellers, spot at max pain for nearest expiry creates a tactical pin. No override.

Supports: Negative GEX (-$638K) supports trending price action; Net premium -$58.9M and P/C vol 1.14 indicate put dominance; Spot at $245 max pain for 3/27 creates a near-term anchor.
Conflicts: Rising max pain ladder ($245 → $260+) suggests longer-term bullish positioning, conflicting with near-term put flow.

📉Negative GEX (-$638K) favors trending moves over pinning.

📊Spot at $245 max pain for 3/27 creates a tactical pin for this week.

📈Max pain ladder rises to $260+ by May, signaling structural bullish drift.

Regime Classification

Vol Regime

Normal

IV 49.2% is very high, offering excellent edge for premium sellers, especially on any volatility crush.

Gamma Regime

Trending

GEX negative (-$638K) — dealers are net long gamma, reducing hedging friction and supporting trending price action.

Flow Regime

Mixed

Mixed — Net premium -$58.9M and P/C vol 1.14 show put dominance, but P/C OI 0.73 reveals more open call interest, indicating a conflict between recent bearish flow and longer-term bullish positioning.

Spot vs Max Pain

At max pain ($245) for the 3/27 expiry, creating a strong near-term pinning force that should resolve by Friday.

Thesis duration: Multi-week — Max pain ladder shows a clear upward trend across expirations ($245 → $260+), GEX sign is stable negative, and flow regime (mixed with put premium but bullish OI) is consistent beyond the immediate weekly pin. This suggests a bullish drift over the next 2-4 weeks.

Price Range Forecast

Next 2 days

$238.48$247.69

Max pain at $245 for 3/27 expiry dominates. Break below $238.48 (2d EM low) invalidates pin and triggers bearish trend.

Next 1 week

$231.63$254.53

Pin releases post-3/27. Negative GEX and put flow favor a test of the 1w EM low at $231.63. Upside capped by $254.53.

Next 2 weeks

$227.73$258.43

Rising max pain ladder and call OI concentration provide a magnet. Downside protected by the massive put floor at $210-$220.

Key Levels

Max pain pins: $245 (2026-03-27); $235 (2026-04-02); $240 (2026-04-10)

EM guardrails: 2d $238.48/$247.69; 1w $231.63/$254.53

Support: $220.00 · $240.00 · $220.00

Resistance: $500.00 · $260.00 · $400.00

Gamma flip: ~$220.00 — Approx — based on put OI concentration of 4,731

Structural: **Call OI wall $260-$500** caps significant upside moves. **Massive put floor $210-$220** (OI ~8K+) provides formidable structural support, making a crash below $210 unlikely without a fundamental catalyst.

Dealer Positioning (GEX/DEX)

GEX: $-638K

DEX: +11.8M shares

Gamma flip: ~$220 (Approx — based on put OI concentration of 4,731)

NTM gamma: Gamma flip is far below at ~$220, indicating minimal dealer hedging pressure near current spot. With negative GEX, a move ±2% from here will see dealers buying dips and selling rallies, amplifying trends.

IV Analysis

IV vs VIX: IV 49.2% is extremely high (no VIX provided for direct comp, but >40% is elevated for ADBE). This is rich vol, favoring premium selling strategies.

Term structure: Steeply upward sloping near-term (35.5% 2d → 45.6% 79d), then flat. The kink at the 6/18 expiry (45.6%) likely prices in the 6/11 earnings event.

Skew: The ~10 vol-point differential between 2-day (35.5%) and 10-day (38.1%) expiries supports short-dated calendar spreads (sell near, buy farther).

Flow Analysis

Net premium: -$58.9M bearish; P/C vol 1.14 (put-heavy), P/C OI 0.73 (call-heavy).

Directional prints: 1) $235P 4/10: Vol 252 vs OI 2,801 — could be opening put sells (bullish) or buys (bearish). Given net put premium, bearish interpretation is more consistent. 2) $260C 4/17: Vol 100 vs OI 3,687 — likely opening call buys, aligning with longer-term bullish max pain drift.

Unusual: $350P 6/18: Vol 300 vs OI 100 at IV 60.9% — deep OTM protective put purchase or speculative bearish bet; expensive vol suggests hedging.

Risks & Catalysts

!**Gamma flip at ~$220 is far away**; a break below could accelerate selling due to negative GEX.

!**3/27 expiry** releases the $245 pin, potentially increasing volatility.

!**High IV (49.2%)** presents vol crush risk for long premium positions.

!**Upcoming earnings on 6/11** is a known catalyst, keeping longer-dated vol elevated.

Strategy Viability

Strategy	Edge	Best Setup	Primary Risk
Long stock	Moderate	Buy shares at $243.08.	Immediate downside to $231.63 (1w EM low) in a trending negative GEX regime.
Short stock	Moderate-Strong	Sell shares at $243.08, target $235.	Strong put floor at $220 and rising max pain create a powerful bullish magnet over time.
Covered call	Strong	Own stock, sell $260C 4/17 (~$2.00 est).	Capped upside if stock rallies toward max pain ladder; stock depreciation.
Cash-secured put / put spread	Moderate-Strong	Sell $235/$230 put spread 4/10 (~$1.50 credit est).	Break below $231.63 (1w EM low).
Long calls	Moderate-Weak	Buy $250C 5/15 (~$11.00 est) for multi-week bullish drift.	High IV (39.5%) and theta decay; near-term pin/pull to $245.
Long puts / bear put spread	Moderate-Strong	Buy $240/$235 put spread 4/10 (~$1.80 debit est).	Pin at $245 holds through 3/27; vol crush on drop.
Iron condor	Weak	$235/$230P x $255/$260C 4/10.	GEX negative (trending) and VIX proxy >28 (IV 49.2%) make range-bound strategies risky.
Calendar/diagonal	Moderate	Sell $245C 4/2 (IV 35.5%), buy $245C 4/10 (IV 38.1%) for a ~2.6 vol-pt credit.	Directional move away from $245; pin breaks.
PMCC / LEAPS diagonal	Moderate-Strong	Buy $210C 1/15/27 (IV 47.2%), sell $260C 4/17 against it.	Capital intensive; near-term stagnation.

Top Plays

Bear Put Spread (Near-Term)

Buy $240 / Sell $235 Put Spread, Exp 4/10

Capitalizes on the negative GEX (trending) regime and near-term put flow, targeting a move toward the 1-week EM low ($231.63) after the 3/27 pin releases. Defined risk in high IV.

Debit: $1.70-$1.90

Max loss: $3.30

BE: $238.30

Mgmt: Take profit at 80-100% of max profit if $231.63 is tagged. Cut loss if spot reclaims $245 post-3/27 expiry.

Traders seeking a defined-risk bearish play aligned with the near-term flow and GEX regime.

Covered Call (Yield + Drift)

Own Stock, Sell $260 Call, Exp 4/17

Harnesses high IV for premium while positioning for the multi-week bullish drift implied by the rising max pain ladder. The $260 strike aligns with a key call OI wall and the 4/17 max pain.

Credit: $1.80-$2.20

Max loss: Unlimited (stock depreciation)

BE: $241.28

Mgmt: Roll up and out if spot approaches $255. Close if premium decays >50% or if bearish thesis strengthens (close below $235).

Stock owners looking to generate income and willing to cap upside at $260 in exchange for downside protection.

LEAPS Diagonal (Structural Bullish)

Buy $210 Call 1/15/27, Sell $260 Call 4/17

The 30+ DTE long leg captures the structural bullish drift (max pain to $310) with low time decay, financed by selling elevated near-term vol against it. The $210 strike is above the massive put floor, providing a margin of safety.

Debit: $32.00-$36.00

Max loss: Debit paid

BE: $242.00

Mgmt: Roll short call monthly, targeting strikes near 30-delta. Close entire position if long-dated max pain trend breaks (e.g., spot below $220).

Traders with larger capital seeking a low-cost, leveraged bullish position for the next 3-6 months, comfortable managing short legs.

Watchlist Triggers

Entry Triggers

IFIf spot closes below $238.48 (2d EM low) after 3/27 expiry → Enter bear put spread: Buy $240 / Sell $235 Put, Exp 4/10.

IFIf spot pulls back to $235 (key support/max pain) and holds for 2 hours → Sell cash-secured $235 Put, Exp 4/17, or enter PMCC (Buy $210C 1/15/27).

Exit Triggers

EXITIf spot breaks below $220 (gamma flip & put floor) → Exit all bullish positions (long stock, covered calls, diagonals).

EXITIf spot rallies to $258.43 (2w EM high) → Take profits on all bearish positions (short stock, put spreads).

Tactical Summary

Primary thesis: Near-term bearish pressure (negative GEX, put flow) targeting $231.63, transitioning to a multi-week bullish drift toward $260+ (rising max pain). Invalidation for bulls is a close below $220. The regime favors directional plays and premium selling. Top plays: 1) Bear put spread for near-term trend, 2) Covered call for stock owners to harvest high vol, 3) LEAPS diagonal for leveraged exposure to the structural bullish drift.

How to Use These Reports

This directional reflects the market close on March 31, 2026.

What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.